Lonidamine plus epirubicin and cyclophosphamide in advanced breast cancer. A phase II study.
Gardin
G
G
Barone
C
C
Nascimben
O
O
Ianniello
G
G
Sturba
F
F
Contu
A
A
Pronzato
P
P
Rosso
R
R
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007191:Indazoles / Q000008:administration & dosage; D008875:Middle Aged
D007191:Indazoles; D015251:Epirubicin; D003520:Cyclophosphamide; C016371:lonidamine